Stay updated with breaking news from Insurance Exchanges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ebix, Inc. (NASDAQ:EBIX – Get Rating) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 5,030,000 shares, a decrease of 13.0% from the February 28th total of 5,780,000 shares. Based on an average trading volume of 370,500 shares, the short-interest ratio is presently 13.6 days. Approximately […]
Ebix, Inc. (NASDAQ:EBIX – Get Rating) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 5,030,000 shares, a decrease of 13.0% from the February 28th total of 5,780,000 shares. Based on an average daily volume of 370,500 shares, the days-to-cover […]
StockNews.com lowered shares of Ebix (NASDAQ:EBIX – Get Rating) from a hold rating to a sell rating in a report published on Friday. Separately, Craig Hallum lowered their price target on shares of Ebix from $40.00 to $35.00 in a report on Thursday, March 16th. Ebix Price Performance Shares of Ebix stock opened at $13.00 […]
Operator: Ladies and gentlemen, good morning. My name is Abby and I will be your conference operator today.
Obamacare—the massive health care law passed in March—constitutes the largest expansion of government since the Great Society. Americans have voiced their strong opposition, but the Obama Administration is determined to force-feed the new medicine. The Administration’s vision of health care is based on the premise that the federal government can—and must—control the details of health care financing and delivery across the country. The Patient Protection and Affordable Care Act (PPACA) is the scaffolding for this control. The new law gives the Administration extensive authority to ach...